- Home
- TNXP vs ILPT Comparison
TNXP vs ILPT Comparison
Compare TNXP & ILPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- ILPT
- Stock Information
- Founded
- TNXP 2007
- ILPT 2017
- Country
- TNXP United States
- ILPT United States
- Employees
- TNXP N/A
- ILPT N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- ILPT Real Estate Investment Trusts
- Sector
- TNXP Health Care
- ILPT Real Estate
- Exchange
- TNXP Nasdaq
- ILPT Nasdaq
- Market Cap
- TNXP 272.0M
- ILPT 303.6M
- IPO Year
- TNXP N/A
- ILPT 2018
- Fundamental
- Price
- TNXP $49.73
- ILPT $5.64
- Analyst Decision
- TNXP Strong Buy
- ILPT Strong Buy
- Analyst Count
- TNXP 2
- ILPT 1
- Target Price
- TNXP $585.00
- ILPT $10.00
- AVG Volume (30 Days)
- TNXP 1.2M
- ILPT 625.1K
- Earning Date
- TNXP 08-15-2025
- ILPT 07-29-2025
- Dividend Yield
- TNXP N/A
- ILPT 0.71%
- EPS Growth
- TNXP N/A
- ILPT N/A
- EPS
- TNXP N/A
- ILPT N/A
- Revenue
- TNXP $10,041,000.00
- ILPT $441,992,000.00
- Revenue This Year
- TNXP $22.87
- ILPT $2.97
- Revenue Next Year
- TNXP $711.66
- ILPT $1.73
- P/E Ratio
- TNXP N/A
- ILPT N/A
- Revenue Growth
- TNXP N/A
- ILPT 0.61
- 52 Week Low
- TNXP $6.76
- ILPT $2.45
- 52 Week High
- TNXP $130.00
- ILPT $6.07
- Technical
- Relative Strength Index (RSI)
- TNXP 70.46
- ILPT 67.17
- Support Level
- TNXP $41.64
- ILPT $5.24
- Resistance Level
- TNXP $46.00
- ILPT $6.07
- Average True Range (ATR)
- TNXP 3.70
- ILPT 0.30
- MACD
- TNXP 0.38
- ILPT -0.03
- Stochastic Oscillator
- TNXP 95.84
- ILPT 71.76
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About ILPT Industrial Logistics Properties Trust of Beneficial Interest
Industrial Logistics Properties Trust is a real estate investment trust. It owns and leases industrial and logistics properties throughout the United States. The company's investment portfolio includes industrial lands in Hawaii and industrial and logistics properties in other states. Rental revenue is earned from Hawaii Properties and Mainland Properties.